Showing results (101-110 of 362) with videos related to

Sort By:
Pageof 37
Materials (Basel, Switzerland)|August 12, 2023
Magnetic Domains and Their Power Spectral Densities in Non-Oriented Electrical Steel after Thermal Compression at Different RatesYuqi Wang, Zhenyu Gao, Li Luo, et al.
Journal of Hepatocellular Carcinoma|April 24, 2026
NLR-PALBI Score and Its Grading: Predicting Overall Survival of Patients with Primary Liver Cancer Undergoing Transcatheter Arterial ChemoembolisationMaoyuan Zhang, Jiyun Zhang, Kunlong Yang, et al.
The Journal of Biological Chemistry|April 26, 2026
Ubiquitin E3 Ligase MYCBP2 Targets KIF14 and Contributes to Acute Myeloid Leukemia ProgressionGuoli Yao, Yang Yang, Chunmei Chen, et al.
Analytical Methods : Advancing Methods and Applications|February 20, 2025
Correction: Strategies for the detection of site-specific DNA methylation and its application, opportunities and challenges in the field of electrochemical biosensorsChenliu Ye, Zhibin Zhao, Penghui Lai, et al.
Bioengineered|March 17, 2020
Biocatalytic synthesis of lactosucrose using a recombinant thermostable β-fructofuranosidase from Arthrobacter sp. 10138Chunmei Chen, Jieying Deng, Xueqin Lv, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 28, 2015
Surgical treatment of pituitary apoplexy in association with hemispheric infarctionZhangyu Zou, Changyun Liu, Bin Sun, et al.
BMC Cardiovascular Disorders|April 30, 2026
Inflammatory-lipid residual risk phenotypes delineate the HFpEF probability spectrum independent of cardiometabolic mediationChunmei Chen, Siqi Zhang, Yuetong Liu, et al.
BMC Cardiovascular Disorders|February 24, 2026
A pragmatic nomogram using routinely collected clinical variables to screen prevalent HFpEF: development and temporal validationChunmei Chen, Yuetong Liu, Xinxin Mao, et al.
RSC Advances|May 2, 2022
Recent advances in the chemistry and biology of azaphilonesChunmei Chen, Huaming Tao, Weihao Chen, et al.
Plos One|October 27, 2025
Hematological toxicity of anti-tumor antibody-drug conjugates: A retrospective pharmacovigilance study using the FDA adverse event reporting systemMei Rao, Lihua Wu, Hong Chen, et al.
Pageof 37